International Agency for Research on Cancer, World Health Organization. Global Cancer Observatory. Cancer Today. International Agency for Rsearch on Cancer.2023;22.

Mehrotra R, Yadav K (2022) Breast cancer in India: present scenario and the challenges ahead. World J Clin Oncol 13(3):209–218

Article  PubMed  PubMed Central  Google Scholar 

Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P (2022) Cancer incidence estimates for 2022 & projection for 2025: result from National Cancer Registry Programme, India. Indian J Med Res 156(4&5):598–607

PubMed  Google Scholar 

Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia MM, Miranda-Filho A, Ferlay J, Parkin DM, Ranganathan R, Piñeros M, Znaor A, Mery L, Joko-Fru YW, Dikshit R, Sankaranarayanan R, Swaminathan R, Bray F; SURVCAN-3 collaborators (2023) Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncol 24(1):22

Sathishkumar K, Vinodh N, Badwe RA, Deo SV, Manoharan N, Malik R, Panse NS, Ramesh C, Shrivastava A, Swaminathan R, Vijay CR, Narasimhan S, Chaturvedi M, Mathur P (2021) Trends in breast and cervical cancer in India under National Cancer Registry Programme: an age-period-cohort analysis. Cancer Epidemiol 74:101982

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M et al (2020) Global cancer statistics: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249

Article  Google Scholar 

Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15–23

Article  PubMed  PubMed Central  Google Scholar 

Karami F, Mehdipour P (2013) A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. Biomed Res Int 928562

Mehrgou A, Akouchekian M (2016) The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. Med J Islam Repub Iran 30:369

PubMed  PubMed Central  Google Scholar 

Fu X, Tan W, Song Q, Pei H, Li J (2022) BRCA1 and breast cancer: molecular mechanisms and therapeutic strategies. Front Cell Dev Biol 10:813457

Article  PubMed  PubMed Central  Google Scholar 

Cortesi L, Rugo HS, Jackisch C (2021) An overview of PARP inhibitors for the treatment of breast cancer. Target Oncol 16(3):255–282

Article  PubMed  PubMed Central  Google Scholar 

Huszno J, Kołosza Z, Grzybowska E (2019) BRCA1 mutation in breast cancer patients: analysis of prognostic factors and survival. Oncol Lett 17(2):1986–1995

CAS  PubMed  Google Scholar 

Górski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzańska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubiński J (2000) Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66(6):1963–1968

Article  PubMed  PubMed Central  Google Scholar 

Richards S, on behalf of the ACMG Laboratory Quality Assurance Committee. Aziz N, Bale S, Bick D, Das S, et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–23

Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Aguilera MA, Meyer R et al (2019) VarSome:the human genomic variant search engine. Bioinformatics 35:197880

Article  Google Scholar 

Ganggayah MD, Taib NA, Har YC, Lio P, Dhillon SK (2019) Predicting factors for survival of breast cancer patients using machine learning techniques. BMC Med Inform Decis Mak 19:48

Article  PubMed  PubMed Central  Google Scholar 

Murthy NS, Agarwal UK, Chaudhry K, Saxena S (2007) A study on time trends in incidence of breast cancer—Indian scenario. Eur J Cancer Care (Engl) 16(2):185–186

Article  CAS  PubMed  Google Scholar 

Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, Zaguia A, Koundal S, Belay A (2022) Global increase in breast cancer incidence: risk factors and preventive measures. Biomed Res Int 2022:9605439

Article  PubMed  PubMed Central  Google Scholar 

Chedda P, Pande S, Dama T, Vinarkar S, Chanekar M, Limaye S et al (2020) Spectrum of germline BRCA mutations in hereditary breast and ovarian cancer syndrome in Indian population: a central reference laboratory experience. Cancer Res Stat Treat 3(1):32–41

Article  Google Scholar 

Mittal A, Deo SVS, Gogia A, Batra A, Kumar A, Bhoriwal S, Pramanik R (2022) Profile of pathogenic mutations and evaluation of germline genetic testing criteria in consecutive breast cancer patients treated at a north indian tertiary care center. Ann Surg Oncol 29:1423–1432

Article  PubMed  Google Scholar 

Kulkarni SS, Nag S, Patra A, Pant HB, Agiwal V, Nirupama AY et al (2023) Prevalence of germline mutations in women with breast and/or Ovarian cancer in a tertiary care center in Pune, India. Int J Mol Immuno Oncol 8:65–71

Article  Google Scholar 

Gogia A, Nithin SG, Pramanik R, Gupta R, Deo SVS, Mathur S, Sharma D, Batra A, Prasad CP, Sagiraju HKR (2023) Prevalence of BRCA1 and BRCA2 mutations in an unselected cohort of Indian women with breast cancer. American Society of Clinical Oncology. Breast Cancer—Metastatic. May 31, 2023

Singh J, Thota N, Singh S, Padhi S, Mohan P, Deshwal S, Sur S, Ghosh M, Agarwal A, Sarin R et al (2018) Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations. Breast Cancer Res Treat 170:1

Article  Google Scholar 

Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A (2021) Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review. Cancers 13(17):4287

Article  PubMed  PubMed Central  Google Scholar 

Ferreyra Y, Rosas G, Cock-Rada AM, Araujo J, Bravo L, Doimi F, Casas J, Clavo MD, Pinto JA, Belmar-López C (2023) Landscapeofgermline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru. Front Oncol 13:1227864

Article  CAS  PubMed  PubMed Central  Google Scholar 

Felix GE, Zheng Y, Olopade OI (2018) Mutations in context: implications of BRCA testing in diverse populations. Fam Cancer 4:471–483

Article  Google Scholar 

Mehta A, Vasudevan S, Sharma SK, Kumar D, Panigrahi M, Suryavanshi M, Gupta G (2018) Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India. Cancer Manag. Res. 10:6505–6516

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mannan AU, Singh J, Lakshmikeshava R, Thota N, Singh S, Sowmya TS, Mishra A, Sinha A, Deshwal S, Soni MR, Chandrasekar A, Ramesh B, Ramamurthy B, Padhi S et al (2016) Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India. J Hum Genet 61:515–522

Article  CAS  PubMed  Google Scholar 

Rashid MU, Muhammad N, Naeemi H, Khan FA, Hassan M, Faisal S, Gull S, Amin A, Loya A, Hamann U (2019) Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study. Hered Cancer Clin Pract. 17:27

Article  PubMed  PubMed Central  Google Scholar 

Surakasula A, Nagarjunapu GC, Raghavaiah KV (2014) A comparative study of pre- and post-menopausal breast cancer: risk factors, presentation, characteristics and management. J Res Pharm Pract 3:12–18

Article  PubMed  PubMed Central  Google Scholar 

Ferreyra Y, Rosas G, Cock-Rada AM, Araujo J, Bravo L, Doimi F, Casas J, Clavo MD, Pinto JA, Belmar-López C (2023) LópezLandscapeof germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru. Front Oncol 13:1227864

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mannan AU, Singh J, Lakshmikeshava R et al (2016) Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India. J Hum Genet 61(6):515–522

Article  CAS  PubMed  Google Scholar 

Hansa J, Kannan R, Ghosh SK (2012) Screening of 185DelAG, 1014DelGT and 3889DelAG BRCA1 mutations in breast cancer patients from North-East India. Asian Pac J Cancer Prev 13:5871–5874

Article  PubMed  Google Scholar 

Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M et al (2004) Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Res Treat 88:177–186

Article  CAS  PubMed  Google Scholar 

Saxena S, Chakraborty A, Kaushal M, Kotwal S, Bhatanager D, Mohil RS et al (2006) Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet 7:75

Article  PubMed  PubMed Central  Google Scholar 

Kadalmani K, Deepa S, Bagavathi S, Anishetty S, Thangaraj K, Gajalakshmi P (2007) Independent origin of 185delAG BRCA1 mutation in an Indian family. Neoplasma 54:51–56